DNA interaction with novel antitumor estradiol-platinum(II) hybrid molecule: A comparative study with cisplatin drug

DNA and Cell Biology

Volumn 27, Issue 2, 2008, Pages 101-107

  N'Soukpo Kossi, Christophe N ^a   Descôteaux, Caroline ^a   Asselin, Éric ^a   Tajmir Riahi, Heidar Ali ^a   Bérubé, Gervais ^a  

^a UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD37 ANTIGEN; CISPLATIN; DNA; ESTRADIOL; GUANINE 7 OXIDE; HYBRID PROTEIN; PHOSPHATE; PLATINUM;

ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CIRCULAR DICHROISM; CONTROLLED STUDY; DNA CONFORMATION; DNA DRUG COMPLEX; DNA STRUCTURE; DRUG BINDING; DRUG STRUCTURE; IN VITRO STUDY; INFRARED SPECTROSCOPY; NONHUMAN; PH MEASUREMENT; PRIORITY JOURNAL; PROTEIN INTERACTION; ULTRAVIOLET RADIATION;

ANTINEOPLASTIC AGENTS; CIRCULAR DICHROISM; CISPLATIN; DNA; ESTRADIOL; INTERCALATING AGENTS; MODELS, BIOLOGICAL; NUCLEIC ACID CONFORMATION; ORGANOPLATINUM COMPOUNDS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 39549121459     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2007.0669     Document Type: Article

References (33)

1. Ahmed Ouameur, A., and Tajmir-Riahi, H.A. (2004). Structural analysis of DNA interactions with biogenic polyamines and cobalt(III)hexamine studied by Fourier transform infrared and capillary electrophoresis. J Biol Chem 279, 42041-42054.
2. Alex, S., and Dupuis, P. (1989). FTIR and Raman investigation of cadmium binding by DNA. Inorg Chim Acta 157, 271-281.
3. Andrushchenko, V.V., Leonenko, Z., van de Sande, H., and Wieser, H. (2002). Vibrational CD (VCD) and atomic force microscopy (AMF) study of DNA interactions: VCD and AFM evidence of DNA condensation. Biopolymers 61, 243-260.
4. Bérubé, G. (2006). Estrogen-linked platinum(II) complexes as anticancer agents. US patent #7,153,844, December 26, 2006.
5. Carmichael, J., DeGraff, W.G., Gazdar, A.F., Minna, J.D., and Mitchell, J.B. (1987). Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47, 936-942.
6. Cepeda, V., Fuertes, M.A., Castilla, J., Alonso, C., Quevedo, C., and Pérez, J.M. (2007). Biochemical mechanisms of cisplatin cytotoxicity. Anticancer Agents Med Chem 7, 3-18.
7. Descôteaux, C., Provencher-Mandeville, J., Mathieu, I., Perron, V., Mandal, S.K., Asselin É., and Bérubé, G. (2003). Synthesis of 17β-estradiol platinum (II) complexes: biological evaluation on breast cancer cell lines. Bioorg Med Chem Lett 13, 3927-3931.
8. Dovbeshko, G.I., Chegel, V.I., Gridina, N.Y., Shishov, O.P., Tryndiak, Y.M., Todor, V.P., and Solyanik, G.I. (2002). Surface enhanced IR absorption of nucleic acids from tumor cells: FTIR reflectance study. Biospectroscopy 67, 470-486.
9. Fouchet, M.-H., and Kozelka, J. (1994). Effect of platinum N7-binding to deoxyguanosine and deoxyadenosine on the H8 and H2 chemical shifts. A quantitative analysis. J Inorg Biochem 53, 261-271.
10. Gagnon, V., St-Germain, M.-È., Descôteaux, C., Provencher-Mandeville, J., Parent, S., Mandal, S.K., Asselin, É., and Bérubé, G. (2004). Biological evaluation of novel estrogen-platinum(II) hybrid molecules on uterine and ovarian cancers - molecular modeling studies. Bioorg Med Chem Lett 14, 5919-5924.
11. Galanski, M., and Keppler, B.K. (2007). Searching for the magic bullet: anticancer platinum drugs which can be accumulated or activated in tumor tissue. Anticancer Agents Med Chem 7, 55-73.
12. Gust, R., and Ott, I. (2007). Preclinical and clinical studies on the use of platinum complexes for breast cancer treatment. Anticancer Agents Med Chem 7, 95-110.
13. Hydes, P.C., and Russell, M.J.H. (1988). Advances in platinum cancer chemotherapy. Advances in the design of cisplatin analogs. Cancer Metastasis Rev 7, 67-89.
14. Jamieson, E.R., and Lippard, S.J. (1999). Structure, recognition, and processing of cisplatin-DNA adducts. Chem Rev 99, 2467-2472.
15. Kankia, B.I., Bukin, V., and Bloomfiled, V.A. (2001). Hexamine cobalt(III)-induced condensation of calf-thymus DNA: circular dichroism and hydration measurements. Nucleic Acids Res 29, 2795-2801.
16. Kelland, L.R., and Farrell, N.P. (2000). In Platinum-Based Drugs in Cancer Therapy (Humana Press, Totowa, New Jersey).
17. Kostova, I. (2006). Platinum complexes as anticancer agents. Recent Patent Anticancer Drug Discov 1, 1-22.
18. Kypr, J., and Vorlickova, M. (2002). Circular dichroism spectroscopy reveals invariant conformation of guanine runs in DNA. Biopolymers (Biospectroscopy) 67, 275-277.
19. Lin, L.P., Huang, L.S., Lin, C.W., Lee, C.K., Chen, J.L., Hsu, S.M., and Lin, S. (2005). Determination of binding constant of DNA-binding drug to target DNA by surface plasmon resonance biosensor technology. Curr Drug Targets Immune Endocr Metabol Disord 5, 61-72.
20. Loprete, D.M., and Hartman, K.A. (1993). Conditions for the stability of the B, C, and Z structural forms of poly(dG-dC) in the presence of lithium, potassium, magnesium, calcium and zinc cations. Biochemistry 32, 4077-4082.
21. Nejedly, K., Chladkova, J., Vorlickova, M., Hrabcova, I., and Kypr, J. (2005). Mapping the B-A conformational transition along plasmid DNA. Nucleic Acids Res 33, e5, 1-8.
22. Perron, V., Rabouin, D., Asselin, É., Parent, S., C.-Gaudreault, R., and Bérubé, G. (2005). Synthesis of 17β-estradiol-linked platinum( II) complexes and their cytocidal activity on estrogen-dependent and independent breast tumor cells. Bioorg Chem 33, 1-15.
23. Potaman, V.N., Bannikov, Y.A., and Shlyachtenko, L.S. (1980). Sedimentation of DNA in ethanol-water solution within the interval of B to A transition. Nucleic Acids Res 8, 635-642.
24. Reedijk, J. (1992). The relevance of hydrogen bonding in the mechanism of action of platinum antitumor compounds. Inorg Chim Acta 198, 873-881.
25. Reichmann, M.E., Rice, S.A., Thomas, C.A., and Doty, P. (1954). A further examination of the molecular weight and size of deoxypentose nucleic acid. J Am Chem Soc 76, 3047-3053.
26. Rosenberg, B., Van Camp, L., and Krigas, T. (1965). Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode. Nature 205, 698-699.
27. Stephanos, J.J. (1996). Drug-protein interactions: two-site binding of heterocyclic ligands to a monomeric hemoglobin. J Inorg Biochem 62, 155-169.
28. Stephanos, J.J., Farina, S.A., and Addison, A.W. (1996). Iron ligand recognition by monomeric hemoglobins. Biochim Biophys Acta 1295, 209-221.
29. Taillandier, E., and Liquier, J. (1992). Infrared spectroscopy of DNA. Methods Enzymol 211, 307-335.
30. Takahara, P.M., Rosenzwelg, A.M., Frederick, C.A., and Lippard, S.J. (1995). Crystal structure of a double-stranded DNA containing the major adduct of the anticancer drug cisplatin. Nature 377, 649-652.
31. Vijayalakshmi, R., Kanthimathi, M., and Subramanian, V. (2000). DNA cleavage by a chromium(III) complex. Biochem Biophys Res Commun 271, 731-734.
32. Vorlickova, M. (1995). Conformational transitions of alternating purin-pyrimidin DNAs in perchlorate ethanol solutions. Biophys J 69, 2033-2043.
33. Wong, E., and Giandomenico, C.M. (1999). Current status of platinum-based antitumor drugs. Chem Rev 99, 2451-2466.